Skip to content
Screener

Perspective Therapeutics CATX Total Current Liabilities

Total Current Liabilities at other companies

Eli Lilly logo
Eli LillyLLY
$47.74B+22.4%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$39.86M+1.6%
Immunome logo
ImmunomeIMNM
$35.71M+56.1%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$335.68M+19.8%
uniQure logo
uniQureQURE
$83.35M+104%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$14.33M-60.1%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$29.3M-21.7%
Net income-$26.8M-24.7%
EPS (diluted)-$0.22+24.1%

Balance sheet

See full
Cash & equivalents$48.5M+68.1%
Total debt$3.9M+11.1%
Total equity$323.9M+21.9%
Total assets$392.0M+26.2%

Cash flow

See full
Operating cash flow-$20.7M-3.5%
CapEx$14.2M+1,284%
Free cash flow-$34.8M-66.1%

Valuation

See full
Market cap$342.14M+25.3%
Enterprise value$297.56M+20.1%

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp

Returns & leverage

See full
Return on equity-39.5%+14.0pp
Debt / equity0.0×
Current ratio6.6×-8.5×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:34 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342512
Line itemJune 30, 2026December 31, 2025
Lease liability1,097623
Accrued personnel expenses5,9727,489
Note payable5756
Total current liabilities36,54428,679
Noncurrent liabilities:
Lease liability, net of current portion1,2691,005
Note payable, net of current portion1,5401,569
Deferred Income (Note 3)26,60026,600

ITEM 1 - FINANCIAL STATEMENTS

FAQ

What is Perspective Therapeutics's total current liabilities?
Perspective Therapeutics (CATX) reported total current liabilities of $36.54M in Q2 2026.
How has Perspective Therapeutics's total current liabilities changed year-over-year?
Perspective Therapeutics's total current liabilities increased by 181.4% year-over-year, from $12.99M to $36.54M.
What is the long-term trend for Perspective Therapeutics's total current liabilities?
Over 5 years (2020 to 2025), Perspective Therapeutics's total current liabilities has grown at a 84.7% compound annual growth rate (CAGR), from $1.34M to $28.68M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Perspective Therapeutics's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude